Understanding long COVID: A call for better diagnosis and treatment

FHS
March 8, 2024
3:00 am

A recent review in Nature Reviews Microbiology summarizes the complex mechanisms, significant impacts, and the urgent need for enhanced diagnostics and treatments for long COVID, affecting over 65 million people globally with diverse, debilitating symptoms and systemic health issues.

Global study reveals shifting trends in ovarian cancer incidence by subtype and region

Study analyzed global patterns and trends in ovarian cancer incidence from 1988 to 2017, highlighting variations by histological subtypes and regions. It revealed significant geographic

December 15, 2024

FDA approves Moderna’s RSV vaccine mRESVIA

The FDA’s nod for mRESVIA comes after the successful Phase III ConquerRSV trial. Credit: lupmotion/shutterstock.com. Moderna has secured approval from the US Food and Drug

June 3, 2024

MarketingRx roundup: Pharma advertisers and March Madness; Novo lands near top of Fast Company’s innovation list

Pharma’s March Madness ad play: The NCAA men’s college basketball playoff is always rife with underdogs, overachievers and millions of fans. Pharma brands already in

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.